Biotechnology
Bio Usawa Takes Strategic Step Into Europe With New Subsidiary In Frankfurt, Germany
Share
KIGALI, Rwanda and FRANKFURT, Germany and SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary, Bio Usawa Biotech Europe GmbH, headquartered in Frankfurt, Germany.
This strategic development marks a significant milestone in Bio Usawa’s mission to bridge African innovation with international research, regulatory, and commercial networks.
Bio Usawa selected Frankfurt for its reputation as one of Europe’s foremost life sciences and pharmaceutical hubs, providing access to leading scientific expertise, strong global partnerships, and a vibrant biotechnology ecosystem.
The new European subsidiary will strengthen Bio Usawa’s ability to collaborate with institutions and companies that share its vision of developing and delivering advanced biologic therapies that reach patients faster and more affordably.
“Establishing Bio Usawa Biotech Europe GmbH represents an important step in Bio Usawa’s journey,” said Dr. Menghis Bairu, CEO and President of Bio Usawa. “We are building a company that connects continents – advancing science from Africa to the world and bringing global expertise back to Africa. Our aim is to develop biotechnology solutions that are innovative, high-quality, and accessible to all.”
The Frankfurt-based entity will serve as Bio Usawa’s European anchor for partnerships, regulatory engagement, and scientific collaboration, reinforcing the company’s role as a bridge between Africa and the global biotechnology community.
As part of its broader vision, Bio Usawa is helping transform Africa’s “brain drain” into “brain gain” — attracting talented scientists and innovators from Africa and friends of Africa across the diaspora who are eager to contribute to the continent’s rapidly evolving biotechnology landscape. By fostering cross-continental collaboration and knowledge exchange, Bio Usawa is demonstrating that scientific excellence transcends borders.
About Bio Usawa, Inc
Bio Usawa is Rwanda’s pioneering biotech company that is dedicated to developing, manufacturing, and commercializing high-quality, affordable biosimilars for patients in Africa. Through partnerships with governments, research institutions, and healthcare providers, Bio Usawa is advancing biotechnology innovation in Africa, by Africans, for Africa – and beyond.
Media Contact:
Daniel Levine
Levine Media Group
+1 510-280-5405
danny@levinemediagroup.com
Frequently Asked Questions
What is Bio Usawa's mission?
Bio Usawa's mission is to bridge African innovation with international research, regulatory, and commercial networks in the biotechnology sector.
Why was Frankfurt chosen for the European subsidiary?
Frankfurt was selected due to its reputation as a leading European life sciences and pharmaceutical hub, offering access to expertise, partnerships, and a vibrant biotechnology ecosystem.
What is Bio Usawa's approach to talent development in Africa?
Bio Usawa aims to transform Africa’s “brain drain” into “brain gain” by attracting talented scientists and innovators to contribute to the continent’s biotechnology landscape.
First published on Wed, Oct 29, 2025
Enjoyed what you read? Great news – there’s a lot more to explore!
Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!
Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.
Head to the TechDogs homepage to Know Your World of technology today!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
Commure Partners With Hughston Clinic To Transform Orthopedic Care With Enterprise AI Platform
Itential And Carahsoft Partner To Deliver Hybrid Cloud Network Automation And Orchestration To The Public Sector
Interface.Ai Unveils Industry-First Agentic Bankgpt Platform That Moves CX From Convenience To Outcomes
VAST Data Partners With Microsoft To Power The Next Wave Of Agentic AI
Eviden-Built JUPITER Supercomputer Hits Exascale Milestone According To The TOP500, A First In Europe
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion